Emcure betting on innovator edge in crowded weight-loss drug market

Generic drug launches are a common event in the pharma sector, leading to increased competition and price erosion. However, the large market size for weight-loss drugs could still offer significant opportunities for new entrants.

• •Semaglutide’s patent expired on Friday.
• •Several top Indian drugmakers will launch cheaper generics immediately.
• •Intense competition expected in the weight-loss drug market.
• •Risk flag: Price erosion due to intense competition
• •Risk flag: Regulatory approvals for generics